Business · 24/02/2010Updated: 10/17/2026 · 1 min read
FDA Amends Pulmonary-Allergy Drugs Advisory Committee Meeting Notice
The US Food and Drug Administration (FDA) is updating a notice regarding a meeting of the Pulmonary-Allergy Drugs Advisory Committee, first announced on February 2, 2010, with no other changes
Original source language: Federal Register — Health and Human ServicesOpen original release →